NICOLA HANANIA to Signal Transduction
This is a "connection" page, showing publications NICOLA HANANIA has written about Signal Transduction.
Connection Strength
0.191
-
Targeting IL-5 in COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:1045-1051.
Score: 0.047
-
Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review. Drug Saf. 2018 05; 41(5):489-509.
Score: 0.043
-
Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs. Curr Opin Pulm Med. 2018 01; 24(1):50-55.
Score: 0.042
-
Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017 Feb; 47(2):161-175.
Score: 0.040
-
New perspectives regarding ?(2) -adrenoceptor ligands in the treatment of asthma. Br J Pharmacol. 2011 May; 163(1):18-28.
Score: 0.007
-
beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol. 2010 Jun; 10(3):254-9.
Score: 0.006
-
Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A. 2009 Feb 17; 106(7):2435-40.
Score: 0.006